Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces updates to NIH websites and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T14:13:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:51:14.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:42:54.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study page is now shown as a 403 Forbidden error, replacing the usual study details and navigation with an access-denied screen.
    Difference
    18%
    Check dated 2026-09-20T19:44:28.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor version update to the page; no study data or visible content appears to be altered.
    Difference
    0.1%
    Check dated 2026-08-30T05:43:31.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5. This appears to be a minor maintenance update with no observable changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T23:27:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.